"Omics" is a general term for a broad discipline of science and engineering that analyses various "omes" that include genome, proteome, metabolome, transcriptome, and interactome to name a few.
Omics technologies (genomics, proteomics, structural genomics, interactomics, metabolomics, epigenomics etc. supported by bioinformatics) go hand in hand with studying properties of corresponding groups of biomolecules or their selected properties on a large scale to obtain a global, integrated view of cellular processes. The vast amount of data generated by omics technologies provides the potential to obtain a global view on molecular and cellular processes that have an impact on health and disease. The high throughput technologies as well as the resulting data provide the base for a highly directed personalised and predictive medicine.
Europe was pioneering in genomics with sequencing the first eukaryotic genome (yeast), sequencing of the first plant genome (Arabidopsis thaliana) and the assembling of the physical and genetic maps of the human genome. Since 2007 over € 570 million has been allocated to collaborative research under the Health theme of FP7 to the areas High-throughput research, Proteomics, Pharmacogenomics and Large Scale data gathering.